Restoration of virulence of escape mutants of H5 and H9 influenza viruses by their readaptation to mice

Journal of General Virology

Volumn 86, Issue 10, 2005, Pages 2831-2838

  Rudneva, Irina A ^a   Ilyushina, Natalia A ^a,b   Timofeeva, Tatiana A ^a   Webster, Robert G ^b   Kaverin, Nikolai V ^a  

^a D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; VIRUS HEMAGGLUTININ;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; EVOLUTIONARY ADAPTATION; FEMALE; GENE SEQUENCE; GLYCOSYLATION; INFLUENZA VIRUS; INFLUENZA VIRUS H9; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS CHARACTERIZATION; VIRUS GENE; VIRUS MUTANT; VIRUS MUTATION; VIRUS STRAIN; VIRUS VIRULENCE; WILD TYPE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANTIBODIES, VIRAL; ANTIGENIC VARIATION; ANTIGENS, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS; MICE; VIRULENCE;

INFLUENZA VIRUS;

EID: 26244434564     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81185-0     Document Type: Article

References (36)

1. Bovin, N. V., Korchagina, E. Yu., Zemlyanukhina, T. V., Byramova, N. E., Galanina, O. E., Zemlyakov, A. E., Ivanov, A. E., Zubov, V. P. & Mochalova, L. V. (1993). Synthesis of polymeric neoglycoconjugates based on N-substituted polyacrylamides. Glycoconj J 10, 142-151.
2. Brown, E. G. (1990). Increased virulence of a mouse-adapted variant of influenza A/FM/1/47 virus is controlled by mutations in genomic segments 4, 5, 7, and 8. J Virol 64, 4523-4533.
3. CDC. (1998). Update: isolation of avian influenza A(H5N1) viruses from humans - Hong Kong, 1997-1998. MMWR Morb Mortal Wkly Rep 46, 1245-1247.
4. Daniels, P. S., Jeffries, S., Yates, P. & 7 other authors (1987). The receptor-binding and membrane-fusion properties of influenza virus variants selected using anti-haemagglutinin monoclonal antibodies. EMBO J 6, 1459-1465.
5. Gitelman, A. K., Kaverin, N. V., Kharitonenkov, I. G., Rudneva, I. A., Sklyanskaya, E. I. & Zhdanov, V. M. (1986). Dissociation of the haemagglutination inhibition and the infectivity neutralization in the reactions of influenza A/USSR/90/77 (H1N1) virus variants with monoclonal antibodies. J Gen Virol 67, 2247-2251.
6. Guan, Y., Poon, L. L. M., Cheung, C. Y. & 10 other authors (2004). H5N1 influenza: a protean pandemic threat. Proc Natl Acad Sci U S A 101, 8156-8161.
7. Guo, Y., Li, J. & Cheng, X. (1999). Discovery of men infected by avian influenza A (H9N2) virus. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 13, 105-108 (in Chinese).
8. Hatta, M., Gao, P., Halfmann, P. & Kawaoka, Y. (2001). Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293, 1840-1842.
9. Hoffmann, E., Stech, J., Guan, Y., Webster, R. G. & Perez, D. R. (2001). Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146, 2275-2289.
10. Hulse, D. J., Webster, R. G., Russell, R. J. & Perez, D. R. (2004). Molecular determinants within the surface proteins involved in the pathogenicity of H5N1 influenza viruses in chickens. J Virol 78, 9954-9964.
11. Ilyushina, N. A., Rudneva, I. A., Gambaryan, A. S., Tuzikov, A. B. & Bovin, N. V. (2004a). Receptor specificity of H5 influenza virus escape mutants. Virus Res 100, 237-241.
12. Ilyushina, N. A., Rudneva, I. A., Gambaryan, A. S. & Kaverin, N. V. (2004b). Changes in the affinity of the hemagglutinin to sialic receptors in the H5 and H9 influenza virus escape mutants. In Options for the Control of Influenza V, International Congress Series, vol. 1263, pp. 773-776. Edited by Y. Kawaoka. Amsterdam: Elsevier.
13. Ilyushina, N., Rudneva, I., Gambaryan, A., Bovin, N. & Kaverin, N. (2004c). Monoclonal antibodies differentially affect the interaction between the hemagglutinin of H9 influenza virus escape mutants and sialic receptors. Virology 329, 33-39.
14. Kaverin, N. V., Rudneva, I. A., Ilyushina, N. A. & 7 other authors (2002). Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants. J Gen Virol 83, 2497-2505.
15. Kaverin, N. V., Rudneva, I. A., Ilyushina, N. A., Lipatov, A. S., Krauss, S. & Webster, R. G. (2004). Structural differences among hemagglutinins of influenza A virus subtypes are reflected in their antigenic architecture: analysis of H9 escape mutants. J Virol 78, 240-249.
16. Kohler, G. & Milstein, C. (1976). Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol 6, 511-519.
17. Kuge, S., Kawamura, N. & Nomoto, A. (1989). Strong inclination toward transition mutation in nucleotide substitutions by poliovirus replicase. J Mol Biol 207, 175-182.
18. Matrosovich, M. N., Zhou, N., Kawaoka, Y. & Webster, R. (1999). The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J Virol 73, 1146-1155.
19. Matrosovich, M. N., Krauss, S. & Webster, R. G. (2001). H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity. Virology 281, 156-162.
20. Mochalova, L., Gambaryan, A., Romanova, J., Tuzikov, A., Chinarev, A., Katinger, D., Katinger, H., Egorov, A. & Bovin, N. (2003). Receptor-binding properties of modern human influenza viruses primarily isolated in Vero and MDCK cells and chicken embryonated eggs. Virology 313, 473-480.
21. Palmer, D. F., Dowdle, W. R., Coleman, M. T. & Schild, G. C. (1975). Advanced Laboratory Techniques for Influenza Diagnosis. Immunology Series No. 6. Atlanta, GA: Centers for Disease Control, US Department of Health, Education and Welfare.
22. Peiris, M., Yuen, K. Y., Leung, C. W., Chan, K H., Ip, P. L. S., Lai, R. W. M., Orr, W. K. & Shortridge, K. F. (1999). Human infection with influenza H9N2. Lancet 354, 916-917.
23. Philpott, M., Easterday, B. C. & Hinshaw, V. S. (1989). Neutralizing epitopes of the H5 hemagglutinin from a virulent avian influenza virus and their relationship to pathogenicity. J Virol 63, 3453-3458.
24. Philpott, M., Hioe, C., Sheerar, M. & Hinshaw, V. S. (1990). Hemagglutinin mutations related to attenuation and altered cell tropism of a virulent avian influenza A virus. J Virol 64, 2941-2947.
25. Reading, P. C., Morey, L. S., Crouch, E. C. & Anders, E. M. (1997). Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J Virol 71, 8204-8212.
26. Reed, L. J. & Muench, H. (1938). A simple method for estimating 50% endpoints. Am J Hyg 27, 493-497.
27. Sanchez, G., Bosch, A., Gomes-Mariano, G., Domingo, F. & Pinto, R. M. (2003). Evidence for quasispecies distributions in the human hepatitis A virus genome. Virology 315, 34-42.
28. Smirnov, Y. A., Lipatov, A. S., Van Beek, R., Gitelman, A. K., Osterhaus, A. D. & Claas, E. C. (2000). Characterization of adaptation of an avian influenza A (H5N2) virus to a mammalian host. Acta Virol 44, 1-8.
29. Speller, S. A., Sangar, D. V., Clarke, B. F. & Rowlands, D. J. (1993). The nature and spatial distribution of amino acid substitutions conferring resistance to neutralizing monoclonal antibodies in human rhinovirus type 2. J Gen Virol 74, 193-200.
30. Sturm-Ramirez, K. M., Ellis, T., Bousfield, B. & 7 other authors (2004). Reemerging H5N1 influenza viruses in Hong Kong in 2002 are highly pathogenic to ducks. J Virol 78, 4892-4901.
31. Tsuchiya, E., Sugawara, K., Hongo, S., Matsuzaki, Y., Muraki, Y., Li, Z.-N. & Nakamura, K. (2002). Effect of addition of new oligosaccharide chains to the globular head of influenza A/H2N2 virus haemagglutinin on the intracellular transport and biological activities of the molecule. J Gen Virol 83, 1137-1146.
32. Tuzikov, A. B., Gambaryan, A. S., Juneja, L. R. & Bovin, N. V. (2000). Conversion of complex sialooligosaccharides into polymeric conjugates and their anti-influenza virus inhibitory potency. J Carbohydr Chem 19, 1191-1200.
33. Webby, R. J., Perez, D. R., Coleman, J. S. & 8 other authors (2004). Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet 363, 1099-1103.
34. Weis, W., Brown, J. H., Cusack, S., Paulson, J. C., Skehel, J. J. & Wiley, D. C. (1988). Structure of the influenza virus hemagglutinin complexed with its receptor, sialic acid. Nature 333, 426-431.
35. WHO. (2005). Outbreak news. Wkly Epidemiol Rec 80, 233-240.
36. Wuethrich, B. (2003). Infectious disease. An avian flu jumps to people. Science 299, 1504.